Skip to main content
Premium Trial:

Request an Annual Quote

Human Longevity Raises $30M From Emerging Technology Partners, Healthcare Investors

NEW YORK – Human Longevity said on Wednesday that it has closed a $30 million financing round from a number of investors.

The round included existing investor Emerging Technology Partners as well as new undisclosed healthcare investors.

The San Diego-based company plans to use the proceeds from the financing to enhance its Health Nucleus intelligence platform, which combines brain and body MRI imaging, whole-genome sequencing, and other lab tests such as cardiac CAT scans and metabolic tests with machine learning and artificial intelligence to create "a comprehensive standard for measuring your health and performance."

The platform provides risk analyses for cardiac, cancer, metabolic, and cognitive health issues.   

Human Longevity's latest funding round follows a $220 million Series B funding that company completed in 2016.

The Scan

Nature Papers on Long Reads for Bacterial Genomes, Zebrafish Atlas, Hypothalamic Aging in Mammals

In Nature this week: near-finished microbial genomes without polishing, zebrafish functional annotation program, and more. 

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.